Skip to content

James M Mock, Chief Financial Officer at Moderna, sold MRNA on Sep 10, 2026

Data as of Oct 16

▼ SELL$2.7M19,836 shares at $134.49James M Mock Chief Financial OfficerMRNA Moderna, Inc.
Watch MRNA
Traded
Sep 10, 2026
Disclosed
Sep 14, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

James M Mock, Chief Financial Officer at Moderna, sold MRNA on Sep 10, 2026TRADEDDISCLOSED
MRNASimilar stocks (XLV — its sector index fund), rebased to MRNA's price on the disclosure day
MRNA since disclosure
+48.6%
after the sale
Similar stocks (XLV) since disclosure
+5.3%
XLV — its sector index fund

Change in closing price from Sep 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJames M Mock Chief Financial OfficerMRNA Moderna, Inc.$2Mdisclosed Sep 14 · filed 4 days after the trade

See every trade on MRNA →